Dr. Brooke Grindlinger, Chief Scientific Officer for The New York Academy of Sciences, discusses the role that philanthropy can play in supporting scientists as well as the importance of supporting girls and women in science fields.
All content for The New York Academy of Sciences is the property of The New York Academy of Sciences and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Dr. Brooke Grindlinger, Chief Scientific Officer for The New York Academy of Sciences, discusses the role that philanthropy can play in supporting scientists as well as the importance of supporting girls and women in science fields.
Clinical trials to evaluate new drugs are typically built around one design, the randomized controlled trial, but this method has come under scrutiny in recent years for being expensive, lengthy, and cumbersome. In this podcast you'll hear from experts asking if alternative designs would be better for determining the safety and efficacy of new therapies.
This podcast was produced following a conference on this topic held in partnership between the NYU School of Medicine and the Academy. It was made possible with support from Johnson and Johnson.
The New York Academy of Sciences
Dr. Brooke Grindlinger, Chief Scientific Officer for The New York Academy of Sciences, discusses the role that philanthropy can play in supporting scientists as well as the importance of supporting girls and women in science fields.
